E board review in Breast Cancer February 2008

Article

E board review in Breast Cancer February 2008

 

 

E-Board Review in Oncology:
Breast Cancer

The board review on breast cancer that follows is designed to help you discern the critical issues relating to the treatment of breast cancer. The subjects covered in this program represent scenarios clinicians face each day and reflect cutting-edge findings reported at major medical meetings. The hope is that the 36 questions and answers in the review will direct your focus in the ever-changing scope of options for breast cancer patients and lead to a higher quality of care and prolonged survival for them. This review should also serve as a valuable resource to help prepare you for the Medical Oncology Board Certification Examination.

After you work through the questions and answers, you can print a PDF of the entire program for future reference-instructions for doing so will appear on your screen after you complete the 36 questions.

In addition, you can earn 3 CME credits after completion of the program. Click on Earn Continuing Medical Education Credit and follow the instructions found there.

We hope you will find this review both interesting and informative-as both a resource for improving patient care and a study guide.

Editor:

Matthew J. Ellis, MB, BChir, PhD, FRCP
Director, Breast Cancer Program
Anheuser Busch Tenured
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, Missouri

Steven M. Sorscher, MD
Assistant Professor of Medicine
Division of Oncology
Director, Siteman Cancer Center, West Country
Washington University School of Medicine
St. Louis, Missouri

Cynthia X. Ma, MD, PhD
Assistant Professor of Medicine
Division of Oncology
Washington University
School of Medicine
St. Louis, Missouri

 

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.